Skip to main content

Diagnostic options Β· UAE

Hereditary Hearing Loss tests in Dubai & UAE

Compare available Hereditary Hearing Loss tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

8

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Hereditary Hearing Loss test prices

Showing 1–8 of 8 matching tests.

Hereditary Hearing Loss diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5630
ESPN Gene Autosomal Recessive Type 36 Genetic Test

This test identifies pathogenic variants in the ESPN gene, the molecular cause of non-syndromic autosomal recessive deafness type 36 (DFNB36).

Whole Blood (Peripheral EDTA) or Buccal Swab 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants (SNVs, indels, splice-site variants) in the ESPN gene", "Stereocilin protein integrity"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Diagnosis of non-syndromic sensorineural hearing loss (DFNB36)", "Recurrence risk assessment for families with DFNB36", "Patients with negative GJB2 mutation screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21653-3 ICD-10: H90.5
Clinical summary
This test identifies pathogenic variants in the ESPN gene, the molecular cause of non-syndromic autosomal recessive deafness type 36 (DFNB36).
TEST-5661
GIPC3 Gene (Autosomal Recessive Deafness Type 15) Genetic Test

This test identifies pathogenic variants within the GIPC3 gene associated with autosomal recessive deafness type 15.

Whole blood (EDTA), extracted DNA, or FTA card 3-4 Weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the GIPC3 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
["No fasting required", "No interruption of regular medications", "Inform genetic counsellor of anticoagulant therapy"]
Indications
["Individuals with clinical features suggestive of DFNB15", "Family history of autosomal recessive hearing loss", "Confirmation of diagnosis for genetic counselling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81320-5 ICD-10: H90.3
Clinical summary
This test identifies pathogenic variants within the GIPC3 gene associated with autosomal recessive deafness type 15.
TEST-5784
GJB2 Gene (Connexin 26) Deafness with Keratopachydermia & Digital Constrictions Genetic Test

This test evaluates the GJB2 gene for variants associated with syndromic hearing loss, specifically Vohwinkel syndrome.

Peripheral Whole Blood (3–5 mL in EDTA tube) or Saliva (Oragene DNA kit) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["GJB2 gene sequence", "Pathogenic variants in GJB2"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any medications"]
Indications
["Suspected Vohwinkel syndrome", "Syndromic hearing loss with skin manifestations"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92946-7 ICD-10: Q87.8, H90.5
Clinical summary
This test evaluates the GJB2 gene for variants associated with syndromic hearing loss, specifically Vohwinkel syndrome.
TEST-5705
PCDH15 Gene Sequencing (Autosomal Recessive Deafness Type 23, NGS) Test

This test identifies mutations in the PCDH15 gene associated with autosomal recessive deafness type 23.

Whole Blood (EDTA), Extracted DNA, or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PCDH15 gene mutations", "Detection of variants (missense, nonsense, frameshift, splice-site)"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counseling is required.", "Do not discontinue prescribed medications without consulting a physician."]
Indications
["Diagnosis of autosomal recessive deafness type 23 (DFNB23)", "Evaluation for cochlear implantation candidacy", "Genetic counseling for families with hereditary hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93025-8 ICD-10: H90.3
Clinical summary
This test identifies mutations in the PCDH15 gene associated with autosomal recessive deafness type 23.
TEST-5765
SIX1 Gene Deafness (Autosomal Dominant Type 23) Genetic Test

This test evaluates the SIX1 gene for pathogenic variants associated with autosomal dominant non-syndromic hearing loss (DFNA23).

Whole Blood (EDTA), Extracted DNA, or FTA Card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the SIX1 gene", "Deletions and duplications within the SIX1 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any current medications"]
Indications
["Diagnosis of non-syndromic hearing loss", "Genetic counseling for families with hearing loss", "Confirmation of suspected DFNA23"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: H90.5
Clinical summary
This test evaluates the SIX1 gene for pathogenic variants associated with autosomal dominant non-syndromic hearing loss (DFNA23).
TEST-5590
TBC1D24 Gene Deafness, Autosomal Recessive Type 86 Genetic Test

This genetic test evaluates the TBC1D24 gene for pathogenic variants associated with autosomal recessive nonsyndromic hearing loss type 86 (DFNB86).

Peripheral Whole Blood (EDTA) 3–4 weeks (21–28 business days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TBC1D24 gene", "Coding exons, splice sites, and exon-intron boundaries of TBC1D24"]
Parameters
[]
Preparation
["No specific fasting required", "No medication or diet restrictions"]
Indications
["Diagnosis of autosomal recessive nonsyndromic hearing loss type 86 (DFNB86)", "Genetic counseling for families with hearing loss", "Carrier screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82236-1 ICD-10: H90.3, Z13.71
Clinical summary
This genetic test evaluates the TBC1D24 gene for pathogenic variants associated with autosomal recessive nonsyndromic hearing loss type 86 (DFNB86).
TEST-5775
TECTA Gene Autosomal Dominant Deafness Type 12 Genetic Test

This genetic test analyzes the TECTA gene for mutations causing autosomal dominant non-syndromic hearing loss (DFNA12). It provides a definitive molecular diagnosis.

Peripheral Whole Blood (EDTA, 3-5 mL) 21 – 28 Business Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the TECTA gene", "Exon coverage of the TECTA gene"]
Parameters
[]
Preparation
["No fasting required", "No alteration to medication schedule required"]
Indications
["Children and adults with early-onset, bilateral sensorineural hearing loss", "Presence of at least one first-degree relative with confirmed hearing impairment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 83397-6 ICD-10: H90.5
Clinical summary
This genetic test analyzes the TECTA gene for mutations causing autosomal dominant non-syndromic hearing loss (DFNA12). It provides a definitive molecular diagnosis.
TEST-5594
TPRN Gene Deafness Autosomal Recessive 79 Genetic Test

This test identifies mutations within the TPRN gene associated with autosomal recessive profound deafness (DFNB79). It uses high-coverage Next-Generation Sequencing to analyze the...

Whole blood (EDTA tube) or dried blood spot (FTA card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["TPRN gene coding region", "Β±10 base-pair flanking intronic boundaries", "Single-nucleotide variants", "Small insertions", "Small deletions"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed therapy without physician instruction"]
Indications
["Diagnosis of autosomal recessive deafness (DFNB79)", "Recurrence risk counselling for families with hearing loss", "Cochlear implant candidacy assessment", "Early intervention planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: H90.3
Clinical summary
This test identifies mutations within the TPRN gene associated with autosomal recessive profound deafness (DFNB79). It uses high-coverage Next-Generation Sequencing to analyze the entire coding region and flanking intronic boundaries.

Category overview

Hereditary Hearing Loss: overview

Understanding the precise genetic factors behind progressive or congenital auditory decline empowers you to make fully informed, proactive decisions for your long-term sensory health. As a specialized offering within our Molecular Genetics services, Hereditary Hearing Loss testing provides an in-depth evaluation of the complex genetic pathways responsible for non-syndromic deafness. By leveraging advanced genomic profiling technology, this focused screening delivers the critical clarity needed to assess inherited susceptibilities, safely guiding proactive audiology monitoring, timely interventions like hearing aids or implants, and specialized genetic counseling. Trusted by patients and specialists across the best diagnostic labs in Dubai and the UAE, DNA Labs guarantees absolute patient confidentiality, uncompromising diagnostic accuracy, and highly efficient turnaround times. Take control of your auditory futureβ€”schedule your hereditary hearing loss testing in UAE, coordinate a seamless clinical sample collection, or reach out to our expert genetic counselors today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.